OXTELLAR XR (Supernus)
Welcome to the PulseAid listing for the OXTELLAR XR drug offered from Supernus. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Supernus |
| NON-PROPRIETARY NAME: | OXCARBAZEPINE |
| SUBSTANCE NAME: | OXCARBAZEPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-01-17 |
| END MARKETING DATE: | 0000-00-00 |
OXTELLAR XR HUMAN PRESCRIPTION DRUG Details:
| Item Description | OXTELLAR XR from Supernus |
| LABELER NAME: | Supernus |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2013-01-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17772-121_46d7dae0-c6f1-42a1-9607-096368c2bb0f |
| PRODUCT NDC: | 17772-121 |
| APPLICATION NUMBER: | NDA202810 |
Other OXCARBAZEPINE Pharmaceutical Manufacturers / Labelers:
